NO118066B - - Google Patents

Download PDF

Info

Publication number
NO118066B
NO118066B NO160494A NO16049465A NO118066B NO 118066 B NO118066 B NO 118066B NO 160494 A NO160494 A NO 160494A NO 16049465 A NO16049465 A NO 16049465A NO 118066 B NO118066 B NO 118066B
Authority
NO
Norway
Prior art keywords
time
devices
mol
register
establishment
Prior art date
Application number
NO160494A
Other languages
Norwegian (no)
Inventor
H Burch
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Publication of NO118066B publication Critical patent/NO118066B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

Fremgangsmåte for fremstilling av nye mikrobiologisk aktive 4-substituerte 2-(5-nitro-2-furyl)-kinazoliner. Process for the production of new microbiologically active 4-substituted 2-(5-nitro-2-furyl)-quinazolines.

hvor R betegner hydrogen, lavere alkyl, hydroksy (lavere) alkyl, lavere alkoksyalkyl eller amino, og R-^ betegner hydroksy (lavere) where R denotes hydrogen, lower alkyl, hydroxy (lower) alkyl, lower alkoxyalkyl or amino, and R-^ denotes hydroxy (lower)

alkyl, lavere alkoksyalkyl eller morfolinopropyl. alkyl, lower alkoxyalkyl or morpholinopropyl.

Fremgangsmåten ifølge oppfinnelsen erkarakterisert vedat en forbindelse med formelen The method according to the invention is characterized by a compound with the formula

omsettes med en forbindelse med formelen is reacted with a compound with the formula

hvor R og R-^ hver har ovenfor angitte betydning. where R and R-^ each have the meaning indicated above.

Ved reaksjonens utførelse er det hensiktsmessig å sammenføre de reagerende stoffer i nærvær av et oppløsningsmiddel som dimetylformamid og å tilføre varme til reaksjonsblandingen for å påskynde reskjonen. Når reaksjonen er avsluttet, tilsettes hensiktsmessig et inert oppløsningsmiddel, hvori det ønskede sluttprodukt har en lav oppløselighet, f.eks. vann eller lettbensin til oppløsningen for å tilveiebringe en separering av faststoff som utvinnes ved filtrering, og ved under behov renses for oppnåelse av det ønskede sluttprodukt. When carrying out the reaction, it is convenient to combine the reacting substances in the presence of a solvent such as dimethylformamide and to add heat to the reaction mixture to speed up the reaction. When the reaction is finished, an inert solvent is conveniently added, in which the desired end product has a low solubility, e.g. water or light petrol to the solution to provide a separation of solid matter which is recovered by filtration, and when necessary purified to obtain the desired end product.

Ovennevnte forbindelser utmerker seg spesielt for sin evne til å hemme tilvekst av mikroorganismer. The above-mentioned compounds are particularly distinguished for their ability to inhibit the growth of microorganisms.

Representativ for den meget kraftige antibakterielle effekt vea foreliggende forbindelser, er den effekt som tilveiebringes av forbindelsen 4-/"bis-(2-hydroksyetyl)-amino7-2-(5-nitro-2-furyl)-kinazolin med et bredt spektrum mot grampositive og gramnegative organismer ved den vanlige teknikk med fortynnede serier. I følgende tabell er 4-/~bis-(2-hydroksyetyl)-amino7-2-(5-nitro-2-furyl)-kinazolin (forbindelse A) sammenlignet med den kjente forbindelse 6-klor-2-(5-nitro-2-furyl)-cinchoninsyre (forbindelse B) med hensyn til hemningsvirkning overfor mikroorganismer. Representative of the very powerful antibacterial effect of the present compounds is the effect provided by the compound 4-/"bis-(2-hydroxyethyl)-amino7-2-(5-nitro-2-furyl)-quinazoline with a broad spectrum against gram-positive and gram-negative organisms by the common dilution series technique In the following table, 4-/~bis-(2-hydroxyethyl)-amino7-2-(5-nitro-2-furyl)-quinazoline (compound A) is compared with the known compound 6-chloro-2-(5-nitro-2-furyl)-cinchoninic acid (compound B) with regard to its inhibitory effect on microorganisms.

Disse forbindelser egner seg således for sammenblanding med egnede bærere i form av pulvere, suspensjoner, salver, spraytilbe-redninger eller lignende for å hindre og utrydde bakterielle smitter. These compounds are thus suitable for mixing with suitable carriers in the form of powders, suspensions, ointments, spray preparations or the like in order to prevent and eradicate bacterial infections.

De nye forbindelser kan også anvendes for å uskadeliggjøre kroppsinfeksjoner ved dyr forårsaket av Staphylococcus aureus. Gjennom peroral administrering i en dose på 50-200 mg/kg på mus, som er dødelig smittet med denne bakterie, hindres dyrene fra å dø. The new compounds can also be used to neutralize body infections in animals caused by Staphylococcus aureus. Through peroral administration in a dose of 50-200 mg/kg to mice, which are fatally infected with this bacterium, the animals are prevented from dying.

For fremstilling av ovennevnte forbindelser kan man anvende følgende forbindelse, nemlig4-klor-2-(5-nitro-2-furyl)-kinazolin, med formelen: For the preparation of the above-mentioned compounds, the following compound can be used, namely 4-chloro-2-(5-nitro-2-furyl)-quinazoline, with the formula:

Dette kan foregå ved at 5_nit.ro-2-furoyl-kloria bringes til omsetning med o-aminobenzamid, f.eks. på følgenae måte: This can take place by reacting 5-nit.ro-2-furoyl-chloria with o-aminobenzamide, e.g. in the following way:

Eksempel A.Example A.

a. 2-( S- nitro- 2- furyl )- 4-( 3H )- kinazolinon.a. 2-(S-nitro-2-furyl)-4-(3H)-quinazolinone.

o-aminobenzamid (6,6 g eller 0,05 mol) oppløses i rj0 crn^ dimetylformamid og eventuelt uoppløselig stoff filtreres fra. Til oppløsningen settes 5i0 g (0,05 mol) kalsiumkarbonat. Unaer omrøring tilsettes 8,75 g (0,05 m°l) 5-nitrofuroylkloria i 20 cm^ aimetylformamid. Blandingen oppvarmes på en varm plate i 1 time. Det uopp-løselige materiale som består av kalsiumklorid og ikke omsatt kalsiumkarbonat filtreres bort. Ved avkjøling gir filtratet 3>9g produkt (utbytte 30%)« Dette kan omkrystalliseres fra tiO crn-^ aimetylformamid. o-Aminobenzamide (6.6 g or 0.05 mol) is dissolved in rj0 crn^ dimethylformamide and any insoluble material is filtered off. 510 g (0.05 mol) of calcium carbonate is added to the solution. Without stirring, 8.75 g (0.05 ml) of 5-nitrofuroyl chloride in 20 cm 3 of aimethylformamide are added. The mixture is heated on a hot plate for 1 hour. The insoluble material consisting of calcium chloride and unreacted calcium carbonate is filtered off. On cooling, the filtrate gives 3>9g of product (yield 30%)« This can be recrystallized from tiO crn-^ aimethylformamide.

Analyse beregnet for 012HyW^O^: C 56,03, H 2,74, N 16,34.Analysis calculated for 012HyW^O^: C 56.03, H 2.74, N 16.34.

Funnet: C 55,9<0>, H 3,00, N 16,31. Found: C 55.9<0>, H 3.00, N 16.31.

b. 4- klor- 2- ( 5- nitro- 2- f uryl)- kinazolin.b. 4-chloro-2-(5-nitro-2-furyl)-quinazoline.

En 5 liters trehalset kolbe utstyrt med omrører, termometer og kjøler tilføres 159 S (0,766 mol) fosforpentaklorid og 790 ml fosforoksyklorid. Den omrørte blanding blandes med I98 g (0,77 mol) av forbindelse omtalt under punkt a i små porsjoner ved værelse-temperatur. Blandingen tilbakeløpkokes i 1 time. Den avkjølte til værelset.emperatur, fortynnes med omtrent 3 1 lettbensin, avkjøles godt og filtreres. Produktet (208 g) renses ved ekstrahering ifølge Soxhlet med toluen. Toluenoppløsningen avkjøles og filtreres. Produktet fåes i form av lange, gule nåler, som smelter ved 196,5~198,5°C i et utbytte på 106 g. A 5 liter three-necked flask equipped with a stirrer, thermometer and condenser is charged with 159 S (0.766 mol) of phosphorus pentachloride and 790 ml of phosphorus oxychloride. The stirred mixture is mixed with 198 g (0.77 mol) of compound mentioned under point a in small portions at room temperature. The mixture is refluxed for 1 hour. It cooled to room temperature, diluted with about 3 1 light petrol, cooled well and filtered. The product (208 g) is purified by extraction according to Soxhlet with toluene. The toluene solution is cooled and filtered. The product is obtained in the form of long, yellow needles, which melt at 196.5~198.5°C in a yield of 106 g.

Analyse beregnet for C^^CIN^: C 52,28, H 2,19, Cl 12,86, Funnet: G 52,38, H 2,14, Cl 12,79. Analysis calculated for C^^CIN^: C 52.28, H 2.19, Cl 12.86, Found: G 52.38, H 2.14, Cl 12.79.

Oppfinnelsen skal forklares nærmere ved hjelp av noen eksempler. The invention will be explained in more detail with the help of some examples.

Eksempel 1. Example 1.

4-/~2-hydroksyetyl(2-hydroksy-propylJamino/-2-(5~nitro-2-furyl)-kinazolin. 4-/~2-Hydroxyethyl(2-hydroxy-propylJamino/-2-(5~nitro-2-furyl)-quinazoline.

En 1 liters trehalset kolbe utstyrt med en omrører tilføres 30 g (0,11 mol) av forbindelsen ifølge eksempel Ab og 26,5 g (0,221 mol) isopropanoletanolamin i 750 ml dimetylformamid. Oppløsningen oppvarmes på dampbad i 1 time. Den fortynnes mea vann til et fast stoff begynner å skille seg ut. Blandingen avkjøles, produktet oppsamles ved filtrering og omkrystalliseres fra isopropylalkohol (Darco). Produktet separeres i form av gule plater, som smelter ved I965 - 1966°C (korr.), i et utbytte på 18 g (46%). A 1 liter three-necked flask equipped with a stirrer is charged with 30 g (0.11 mol) of the compound according to Example Ab and 26.5 g (0.221 mol) of isopropanolethanolamine in 750 ml of dimethylformamide. The solution is heated on a steam bath for 1 hour. It is diluted with water until a solid begins to separate. The mixture is cooled, the product is collected by filtration and recrystallized from isopropyl alcohol (Darco). The product is separated in the form of yellow plates, which melt at 1965 - 1966°C (corr.), in a yield of 18 g (46%).

Analyse beregnet for C-^H^N^O^: C 56,98, H 5,06, N 15,64. Funnet: C 57,14, N 5,25, N 15,65. Eksempel 2. Analysis calculated for C-^H^N^O^: C 56.98, H 5.06, N 15.64. Found: C 57.14, N 5.25, N 15.65. Example 2.

4- bis( 2- hydroksypropyl) amino- 2-( 5- nitro- 2- furyl)- kinazolin.4-bis(2-hydroxypropyl)amino-2-(5-nitro-2-furyl)-quinazoline.

En 1 liters trehalset kolbe utstyrt med en omrører, tilføres4O g (0,145mol) av forbindelsen fremstilt ifølge eksempel Ab, og 40 g (0,3 mol) l,l-iminodi-2-propanol i 500 ml dimetylformamid. Opp-løsningen oppvarmes på dampbad i 2 timer. Den fortynnes med vann til et fast stoff begynner å separere ut. Blandingen avkjøles, det rå produkt oppsamles ved filtrering og omkrystallisering fra isopropylalkohol. Produktet adskilles i form av gule nåler som smelter ved 179 - 170°C (korr.) i et utbytte på 39 g (73%). A 1 liter three-necked flask equipped with a stirrer is charged with 40 g (0.145 mol) of the compound prepared according to Example Ab, and 40 g (0.3 mol) of 1,1-iminodi-2-propanol in 500 ml of dimethylformamide. The solution is heated on a steam bath for 2 hours. It is diluted with water until a solid begins to separate out. The mixture is cooled, the crude product is collected by filtration and recrystallization from isopropyl alcohol. The product separates in the form of yellow needles which melt at 179 - 170°C (corr.) in a yield of 39 g (73%).

Analyse beregnet for C^gHggN^O^: C 58,06, H 5,41, N 15,05.Analysis calculated for C^gHggN^O^: C 58.06, H 5.41, N 15.05.

Funnet: C 57,94, H 5,55, N 14,81. Eksempel 3»Found: C 57.94, H 5.55, N 14.81. Example 3»

4- butyl( 2- hydroksyetyl)- amino- 2-( 5- nitro- 2- furyl)- kinazolin.4-butyl(2-hydroxyethyl)-amino-2-(5-nitro-2-furyl)-quinazoline.

En 1 liters trehalset kolbe utstyrt med en omrører, tilføres 4O g (0,145mol) av forbindelsen fremstilt ifølge eksempel Ab, og 36 g (0,3 mol) N-butyletanolamin i 500 ml dimetylformamid. Oppløs-ningen oppvarmes på et dampbad under omrøring i 2 timer. Oppløsningen fortynnes med vann, til et fast stoff begynner å skille seg ut. Blandingen avkjøles, det gule, faste stoff oppsamles ved filtrering og omkrystalliseres fra isopropylalkohol. Produktet utvinnes i form av gule nåler som smelter ved 120 - 121°C (korr.) i et utbytte på 39 g (75°/°). A 1 liter three-necked flask equipped with a stirrer is charged with 40 g (0.145 mol) of the compound prepared according to Example Ab, and 36 g (0.3 mol) of N-butylethanolamine in 500 ml of dimethylformamide. The solution is heated on a steam bath with stirring for 2 hours. The solution is diluted with water until a solid begins to separate. The mixture is cooled, the yellow solid is collected by filtration and recrystallized from isopropyl alcohol. The product is recovered in the form of yellow needles which melt at 120 - 121°C (corr.) in a yield of 39 g (75°/°).

Analyse beregnet for C^H^N 0 : G 60,66, H 5,66, N 15,72.Analysis calculated for C^H^N 0 : G 60.66, H 5.66, N 15.72.

Funnet: C 60,76, N 5,76, N 15,76. Eksempel 4. Found: C 60.76, N 5.76, N 15.76. Example 4.

4- bis-( 2- hydroksyetyl)- amino- 2-( 5- nitro- 2- furyl)- kinazolin.4- bis-(2- hydroxyethyl)- amino- 2-( 5- nitro- 2- furyl)- quinazoline.

En 500 ml trehalset kolbe utstyrt med omrører, tilføresA 500 ml three-necked flask fitted with a stirrer is added

30,2 g (0,11 mol) av forbindelsen ifølge eksempel Ab og 20,3 g (0,25 mol) dietanolamin i 300 mldimetylformamid. Oppløsningen oppvarmes på dampbad i 2 timer. Oppløsningen fortynnes med vann til det begynner å utskille seg et fast stoff. Blandingen avkjøles, 30.2 g (0.11 mol) of the compound according to example Ab and 20.3 g (0.25 mol) diethanolamine in 300 ml dimethylformamide. The solution is heated on a steam bath for 2 hours. The solution is diluted with water until a solid begins to separate. The mixture is cooled,

og råproduktet oppsamles ved filtrering og omkrystallisering fra etanol. Produktet separeres i form av gule plater, som smelter ved 162,5 - I64,5°C (korr.), i et utbytte på 22 g (569b). and the crude product is collected by filtration and recrystallization from ethanol. The product is separated in the form of yellow plates, which melt at 162.5 - 164.5°C (corr.), in a yield of 22 g (569b).

Ytterligere omkrystallisering fra etanol gir et gult, fast stoff, som smelter ved 167 - l68°C (korr.). Further recrystallization from ethanol gives a yellow solid, melting at 167 - 168°C (corr.).

Analyse beregnet for C-^H^N^O^:C 55,8l, H 4,68, N 16,27-Analysis calculated for C-^H^N^O^: C 55.8l, H 4.68, N 16.27-

Funnet: C 55,90, H 4,75, N 16,36. Eksempel 5» Found: C 55.90, H 4.75, N 16.36. Example 5»

4-/~( 2- hydroksyetyl)- metylamino7- 2-( 5- nitro- 2- furyl)- kinazolin.4-(2-Hydroxyethyl)-methylamino7-2-(5-nitro-2-furyl)-quinazoline.

En blanding av 50 g (0,l82 mol) av forbindelsen ifølge eksempel Ab, og 34g (0,45 mol) N-metyletanolamin i 1 liter bensen tilbakeløpskokes i 1 time. Et fast, brunt stoff fåes ved avkjøling av blandingen. Stoffet oppslemmes i koldt vann og gjøres basisk med en vannholdig natrium-hydroksydoppløsning. Det rå, brune faste stoff oppsamles ved filtrering og omkrystalliseres fra fortynnet vannholdig dimetylformamid til et produkt i form av brune plater som smelter ved 151-152°C (korr.), i et utbytte på 40 g (70%). A mixture of 50 g (0.182 mol) of the compound according to example Ab and 34 g (0.45 mol) N-methylethanolamine in 1 liter of benzene is refluxed for 1 hour. A solid, brown substance is obtained by cooling the mixture. The substance is suspended in cold water and made basic with an aqueous sodium hydroxide solution. The crude brown solid is collected by filtration and recrystallized from dilute aqueous dimethylformamide to a product in the form of brown plates melting at 151-152°C (corr.), in a yield of 40 g (70%).

Analyse beregnet for C^H^N^: C 57,32, H4,49, N 17,03.Analysis calculated for C^H^N^: C 57.32, H 4.49, N 17.03.

Funnet. C 57,25, H 4,56, N 18,01. Found. C 57.25, H 4.56, N 18.01.

Eksempel 6.Example 6.

4-( 2- metoksyetyl)- amino- 2-( 5- nitro- 2- furyl)- kinazolin.4-(2-Methoxyethyl)-amino-2-(5-nitro-2-furyl)-quinazoline.

En 2 liters trehalset kolbe utstyrt med omrører, kjøler og propp, tilføres4O g (0,145mol) av forbindelsen ifølge eksempel Ab og 22,56(0,3 mol) 2-metoksyetylamin i 1 liter benzol. Blandingen tilbakeløpskokes i 1 time. Den avkjølte blanding fortynnes med lettbensin. Råproduktet oppsamles ved filtrering og omkrystalliseres fra metylalkohol. Produktet separeres i form av gule nåler som smelter ved 155-157°C i et utbytte på 26 g (57%). A 2 liter three-necked flask equipped with a stirrer, cooler and stopper is charged with 40 g (0.145 mol) of the compound according to example Ab and 22.56 (0.3 mol) of 2-methoxyethylamine in 1 liter of benzene. The mixture is refluxed for 1 hour. The cooled mixture is diluted with light petrol. The crude product is collected by filtration and recrystallized from methyl alcohol. The product is separated in the form of yellow needles which melt at 155-157°C in a yield of 26 g (57%).

Ytterligere omkrystalliseringer fra metylalkoholøker smeltepunktet til l60 - 162°C (korr.). Further recrystallizations from methyl alcohol increase the melting point to 160 - 162°C (corr.).

Analyse beregnet for C-^H-^N^O^: G 57,32, H4,49, N 17,83.Analysis calculated for C-^H-^N^O^: G 57.32, H 4.49, N 17.83.

Funnet: G 57,30, H 4,bl, N 17,74.Found: G 57.30, H 4.bl, N 17.74.

Eksempel 7.Example 7.

4-( 3- metoksypropylamino)- 2-( 5- nitro- 2- furyl)- kinazolin.4-(3-Methoxypropylamino)-2-(5-nitro-2-furyl)-quinazoline.

En 1 liters trehalset kolbe utstyrt med en omrører tilføresA 1 liter three-necked flask fitted with a stirrer is added

35 g (0,127 mol) av forbindelsen ifølge eksempel Ab og 23,1 g (0,26 mol) metoksypropylamin i 500 ml dimetylformamid. Oppløsningen oppvarmes på aampbad i 2 timer. Den fortynnes med vann til et fast stoff begynner å skille seg ut. Blandingen avkjøles, råproduktet oppsamles ved filtrering og omkrystalliseres fra isopropylalkohol. Produktet separerer i form av gule plater som smelter ved 143-145°^ 35 g (0.127 mol) of the compound according to example Ab and 23.1 g (0.26 mol) of methoxypropylamine in 500 ml of dimethylformamide. The solution is heated on a steam bath for 2 hours. It is diluted with water until a solid begins to separate. The mixture is cooled, the crude product is collected by filtration and recrystallized from isopropyl alcohol. The product separates in the form of yellow plates melting at 143-145°^

(korr.), i et utbytte på 33 g (82%).(corr.), in a yield of 33 g (82%).

Analyse beregnet for: C^H^N^O^: C 58,53, N 4,91, N 17,07Analysis calculated for: C^H^N^O^: C 58.53, N 4.91, N 17.07

Funnet: C 58,68, H 4,80, N 16,67. Eksempel 8. Found: C 58.68, H 4.80, N 16.67. Example 8.

4- bis( 2- etoksyetyl) amino- 2-( 5- nitro- 2- furyl)- kinazolin.4-bis(2-ethoxyethyl)amino-2-(5-nitro-2-furyl)-quinazoline.

En 2 liters trehalset kolbe med omrører tilføres 35 SA 2 liter three-necked flask with a stirrer is added to 35 S

(0,127 mol) av forbindelsen ifølge eksempel Ab og 42 g (0,26 mol) dietoksyetylamin i 1 liter dimetylformamid. Oppløsningen oppvarmes pådampbad under omrøring i 2 timer. Oppløsningen fortynnes med vann til det faste stoff begynner å skille seg ut. Blandingen avkjøles, råproduktet oppsamles ved filtrering og omkrystalliseres fra isopropylalkohol. Produktet separerer ut i form av gule nåler som smelter ved 60 - 6l°C (korr.) i et utbytte på 40 g (79%). (0.127 mol) of the compound according to example Ab and 42 g (0.26 mol) of diethoxyethylamine in 1 liter of dimethylformamide. The solution is heated on a steam bath with stirring for 2 hours. The solution is diluted with water until the solid begins to separate. The mixture is cooled, the crude product is collected by filtration and recrystallized from isopropyl alcohol. The product separates out in the form of yellow needles which melt at 60 - 61°C (corr.) in a yield of 40 g (79%).

Analyse beregnet for<C>20<H>24N4°5: ° 59,99, H 6'04"' N 13»99Analysis calculated for<C>20<H>24N4°5: ° 59.99, H 6'04"' N 13»99

Funnet; C 60,03,, H 5,85, N 14,13. Found; C 60.03, H 5.85, N 14.13.

Eksempel Q.Example Q.

4- ( 2- hydroksyetyl ) amino- 2- ( 5- nitro- 2- furyl )- kinazolin.4-(2-hydroxyethyl)amino-2-(5-nitro-2-furyl)-quinazoline.

En oppløsning av forbindelsen fra eksempel Ab (30,2 g, 0,11 mol) og 15 g (0,25 mol) 2-etanolamin i 800 ml dimetylformamid oppvarmes på dampbad i 2 timer. Oppløsningene fortynnes med vann til det faste stoff begynner å skille seg ut. Blandingen avkjøles og filtreres, idet det fåes et lyst gult fast stoff. Ved omkrystallisering fra etanol fåes produktet i et utbytte på 31 g (94%)« (Smeltepunkt 221 - 223°C). A solution of the compound from example Ab (30.2 g, 0.11 mol) and 15 g (0.25 mol) of 2-ethanolamine in 800 ml of dimethylformamide is heated on a steam bath for 2 hours. The solutions are diluted with water until the solid begins to separate. The mixture is cooled and filtered, obtaining a light yellow solid. Upon recrystallization from ethanol, the product is obtained in a yield of 31 g (94%)« (Melting point 221 - 223°C).

Analyse beregnet for clzj.H12N4°4: C H4.03, N 18,66.Analysis calculated for clzj.H12N4°4: C H4.03, N 18.66.

Funnet: C 56,05, H 4,41, N 18,48. Found: C 56.05, H 4.41, N 18.48.

Eksempel 10. Example 10.

4-/ 3-( 4- morfolino) propyl7- amino- 2-( 5- nitro- 2- furyl)- kinazolinT dihydroklorid. 4-/3-(4-morpholino)propyl7-amino-2-(5-nitro-2-furyl)-quinazolineT dihydrochloride.

En 2 liters trehalset kolbe utstyrt med omrører, kjøler ogA 2 liter three-necked flask equipped with a stirrer, cooler and

kork tilføres 30,2 g (0,11 mol) av forbindelsen fra eksempel Ab og 36 g (0,25 mol) 3_aminoP1''C)Pylmorfolin i 750 ml benzol og tilbakeløps-kokes i 1 1/2 time. Blandingen avkjøles og fortynnes med lettbensin. Et gult, fast stoff oppsamles ved filtrering, oppslemmes i koldt vann og gjøres basisk med en natriumhydroksyd-oppløsning. Den frie base som smelter ved 164 - l66°C oppsamles gjennom filtrering i et utbytte på 42 g (100%). Ved omkrystallisering fra etanol fåes et produkt i form av gule skiver som smelter ved 170 - 171,5°C (korr.). cork is added to 30.2 g (0.11 mol) of the compound from example Ab and 36 g (0.25 mol) 3_aminoP1''C)Pylmorpholine in 750 ml of benzene and refluxed for 1 1/2 hours. The mixture is cooled and diluted with light petrol. A yellow solid is collected by filtration, slurried in cold water and basified with a sodium hydroxide solution. The free base melting at 164 - 166°C is collected by filtration in a yield of 42 g (100%). Upon recrystallization from ethanol, a product is obtained in the form of yellow disks which melt at 170 - 171.5°C (corr.).

Analyse beregnet for C-^Hg-^N^O^: C 59,52, H 5,52, N 18,27.Analysis calculated for C-^Hg-^N^O^: C 59.52, H 5.52, N 18.27.

Funnet: C 59,69, H 5,50, N 18,28. Found: C 59.69, H 5.50, N 18.28.

Den fri base (40 g, 0,104mol) oppløses i 500 ml iseddik og vannfritt klorhydrogen bobles inn i oppløsningen til mettning. Blandingen avkjøles og fortynnes medvannfri eter. Et gult, fast The free base (40 g, 0.104 mol) is dissolved in 500 ml of glacial acetic acid and anhydrous hydrogen chloride is bubbled into the solution until saturation. The mixture is cooled and diluted with anhydrous ether. A yellow, firm

stoff oppsamles ved filtrering og omkrystalliseres fra etanol til et hydroklorid i form av et gult, fast stoff som smelter ved 211-213°C substance is collected by filtration and recrystallized from ethanol to a hydrochloride in the form of a yellow solid melting at 211-213°C

i et utbytte på 30 g (63,5%).in a yield of 30 g (63.5%).

Analyse beregnet for C-^H^N^O^HCl: C 50,00, N 5,08, Cl 15,34, Funnet: C 50,07, N 5,02, Cl 15,07. Eksempel 11. Analysis calculated for C-^H^N^O^HCl: C 50.00, N 5.08, Cl 15.34, Found: C 50.07, N 5.02, Cl 15.07. Example 11.

4-( 3- hydroksypropylamino)- 2-( 5- nitro- 2- furyl)- kinazolin.4-(3-hydroxypropylamino)-2-(5-nitro-2-furyl)-quinazoline.

En 1 liters trehalset kolbe utstyrt med en omrører tilføresA 1 liter three-necked flask fitted with a stirrer is added

35 g (0,127 mol) av forbindelsen fra eksempel Ab og 19,5 g (0,26 mol) 3-aminopropanol i 500 ml dimetylformamid. Blandingen oppvarmes pa dampbad under omrøring i 1 time. Oppløsningen fortynnes med vann og avkjøles. Det brune produkt oppsamles ved filtrering og omkrystalli seres fra acetonitril. Produktet separerer i form av gule plater som smelter ved 108 - l83°C (Korr.) i et utbytte på 22 g (55%). Analyse beregnet for C^H^N^O^: C 57,32, H 4.49»N 17,83. Funnet: C 57,55, N 4.50, N 17,8l. Eksempel 12. 35 g (0.127 mol) of the compound from example Ab and 19.5 g (0.26 mol) of 3-aminopropanol in 500 ml of dimethylformamide. The mixture is heated on a steam bath with stirring for 1 hour. The solution is diluted with water and cooled. The brown product is collected by filtration and recrystallized from acetonitrile. The product separates in the form of yellow plates which melt at 108 - 183°C (Corr.) in a yield of 22 g (55%). Analysis calculated for C^H^N^O^: C 57.32, H 4.49»N 17.83. Found: C 57.55, N 4.50, N 17.8l. Example 12.

4-/~ l-( 2- hydroksyetyl)- hydrazino7- 2-( S- nitro- 2- furyl)- kinazolin.4-[1-(2-hydroxyethyl)-hydrazino-7-2-(S-nitro-2-furyl)-quinazoline.

En 1 liters trehaDæt kolbe utstyrt med omrører tilføresA 1 liter three-headed flask equipped with a stirrer is added

4O g (0,45mol) av forbindelsen fra eksempel Ab og 28,5 g (22,8 g, 0,3 mol) 80%-ig hydroksyetylhydrazin i 500 ml dimetylformamid. Blandingen hensettes i 15 minutter. Temperaturen nærmer seg ca. 40°C. Oppløsningen oppvarmes derpå til bO°C. Den fortynnes med vann og blandingen avkjøles. Det faste stoff oppsamles ved filtrering for å gi 43 g (94%), 34 g av dette produkt omkrystalliseres fra nitrometan for å gi gule nåler som smelter ved 186 - l88°C (korr. ) i et utbytte på 28 g. 40 g (0.45 mol) of the compound from example Ab and 28.5 g (22.8 g, 0.3 mol) of 80% hydroxyethylhydrazine in 500 ml of dimethylformamide. The mixture is left for 15 minutes. The temperature approaches approx. 40°C. The solution is then heated to bO°C. It is diluted with water and the mixture is cooled. The solid is collected by filtration to give 43 g (94%), 34 g of this product is recrystallized from nitromethane to give yellow needles melting at 186 - 188°C (corr. ) in a 28 g yield.

Ved ytterligere omkrystallisering av nitrometan økes smeltepunktet til 190 - 191°C (korr.). By further recrystallization of nitromethane, the melting point is increased to 190 - 191°C (corr.).

Analyse beregnet for C-^H^N^O^: C 53,33, H4,16, N 22,22Analysis calculated for C-^H^N^O^: C 53.33, H4.16, N 22.22

Funnet: C 53,33, H 4,29, N 22,43-Eksempel 13-4-/~( 2- hydroksyetyl) isopropylamino7- 2-( 5- nitro- 2- furyl) kinazolin. Found: C 53.33, H 4.29, N 22.43-Example 13-4-(2-hydroxyethyl)isopropylamino7-2-(5-nitro-2-furyl)quinazoline.

En 1 liters trehalset kolbe utstyrt med omrører tilføresA 1 liter three-necked flask fitted with a stirrer is added

35 g (0,127 mol) av forbindelsen fra eksempel Ab og 25 g (0,242 mol) M-isopropyletanolamin i 500 ml dimetylformamid. Oppløsningen oppvarmes på dampbad i 2 timer. Oppløsningen fortynnes med vann til et fast stoff skiller seg ut og blandingen avkjøles. Produktet oppsamles ved filtrering og omkrystalliseres fra isopropylalkohol. 35 g (0.127 mol) of the compound from example Ab and 25 g (0.242 mol) of M-isopropylethanolamine in 500 ml of dimethylformamide. The solution is heated on a steam bath for 2 hours. The solution is diluted with water until a solid separates and the mixture is cooled. The product is collected by filtration and recrystallized from isopropyl alcohol.

Det separeres i form av gule plater som smelter ved I48 - 150°C iIt separates in the form of yellow plates which melt at I48 - 150°C i

et utbytte på 21 g (48%).a yield of 21 g (48%).

Ved fortsatt omkrystallisering fra isopropylalkohol øker smeltepunktet til 157 - 158°C (korr.). With continued recrystallization from isopropyl alcohol, the melting point increases to 157 - 158°C (corr.).

Analyse beregnet for C^H-j^N^O^: C 59,64, H 5,30, N 16,37. Funnet: C 59,70, N 5,38, N 16,50. Analysis calculated for C^H-j^N^O^: C 59.64, H 5.30, N 16.37. Found: C 59.70, N 5.38, N 16.50.

Claims (4)

1. Kontrollanordning for automatisk indikering av feilaktige forbindelsesetableringer og adskillelse av disse fra etableringer som følge av sperringer, samt blokering av koblingsorganer med feil i veilgerutstyr i automatiske telekommunikasjonsanlegg, hvor styringer av koblingsorganene kontrolleres ved kvitteringssig-1. Control device for automatic indication of erroneous connection establishment and separation of these from establishment as a result of blockages, as well as blocking of switching devices with errors in signaling equipment in automatic telecommunications systems, where controls of the switching devices are checked by receipt sig- naler eller svarsignaler som gis når en koblefase er påbegynt og/eller avsluttet,karakterisert ved at kontrollanordningen er innrettet til, når kvitteringssignal er uteblitt at styresignaler er utsendt, automatisk å fastholde forbindelsen frem til det organ hvor der opptrer feil, uavhengig av om anropet er avsluttet fra foregående organ (såkalt låsing), og at den automatiske fastholdelse opphører når kvitteringssignal er mottatt, og at der er anordnet en tidsinnretning som etter en fast eller innstillbar tid som er større enn den midlere ventetid ved sperrede anrop, markerer at organ med feil er blitt tilkoblet under etableringen og gir alarm til overvåkningspersonalet eller til registrerende organer. nals or response signals that are given when a connection phase has begun and/or ended, characterized in that the control device is designed to, when an acknowledgment signal has not been received that control signals have been sent, automatically maintain the connection until the body where an error occurs, regardless of whether the call is terminated from the preceding body (so-called locking), and that the automatic retention ceases when an acknowledgment signal is received, and that a timer is arranged which, after a fixed or adjustable time that is greater than the average waiting time for blocked calls, marks that the body with an error has been connected during the establishment and gives an alarm to the monitoring staff or to recording bodies. 2. Anordning ifølge påstand 1, karakterisert ved at anordninger (R4) som i avhengighet av et kvitteringssignal opphever fastholdelsen, er forbundet med tidsinnretningen (T-10m, R7) på en slik måte at anordningene for opphevelse av fastholdelsen gjøres uvirksomme når tidsinnretningen trer i funksjon for feilindikering, slik at fastholdelsen bibeholdes hvis kvitteringssignal mottas etter at tidsinnstillingen er trådt i funksjon for feilindikering. 2. Device according to claim 1, characterized in that devices (R4) which, depending on an acknowledgment signal, cancel the hold, are connected to the timing device (T-10m, R7) in such a way that the devices for canceling the hold are rendered ineffective when the time device kicks in function for error indication, so that the retention is maintained if an acknowledgment signal is received after the time setting has entered the function for error indication. 3. Anordning ifølge påstand 1 eller 2, karakterisert ved at tidsinnretningen påvirker anordningene for å fastholde engasjerte velgerorganer med en viss tidsfor-sinkelse, slik at fastholdelsen trer i funksjon etter en tid som overskrider den normale etableriingstid, men er kortere enn den tid, etter hvilken tidsinnretningen trer i virksomhet for feilindikering. 3. Device according to claim 1 or 2, characterized in that the timing device affects the devices for retaining engaged voter bodies with a certain time delay, so that the retention comes into operation after a time that exceeds the normal establishment time, but is shorter than the time, after which the timing device comes into operation for fault indication. 4. Anordning ifølge en eller flere av de foregående påstander, hvor anordningen inngår i et register som kan kobles til av registret styrte velgerorganer ved hjelp av et registertilslutnlngsorgan (RFV) og som omfatter et relé (R2) som påvirkes ved anrop fra en anropende ledning og derved slutter en holdestrømkrets for registertil-slutningsorganet, karakterisert ved at anordningene som bevirker fastholdelse av engasjerte velgerorganer, omfatter en anordning (R6) for etablering av en annen holdestrømkrets for registertilslutnings-organet, hvilken holdestrømkrets er uavhengig av den førstnevnte holdestrømkrets. Tysk patent nr. 881 071, 881 691, 903 349, 286 814.4. Device according to one or more of the preceding claims, where the device is part of a register which can be connected to voter bodies controlled by the register by means of a register connection device (RFV) and which comprises a relay (R2) which is affected by calls from a calling line and thereby ends a holding current circuit for the register connection device, characterized in that the devices which effect retention of engaged selector devices include a device (R6) for establishing another holding current circuit for the register connection device, which holding current circuit is independent of the first-mentioned holding current circuit. German Patent No. 881,071, 881,691, 903,349, 286,814.
NO160494A 1964-12-14 1965-11-16 NO118066B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US418311A US3324122A (en) 1964-12-14 1964-12-14 Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines

Publications (1)

Publication Number Publication Date
NO118066B true NO118066B (en) 1969-11-03

Family

ID=23657580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO160494A NO118066B (en) 1964-12-14 1965-11-16

Country Status (14)

Country Link
US (1) US3324122A (en)
AT (1) AT255424B (en)
BE (1) BE672504A (en)
BR (1) BR6575667D0 (en)
CH (1) CH448110A (en)
DE (1) DE1620076A1 (en)
DK (1) DK117902B (en)
ES (1) ES318292A1 (en)
FR (2) FR1460221A (en)
GB (1) GB1101179A (en)
IL (1) IL24359A (en)
NL (1) NL6513634A (en)
NO (1) NO118066B (en)
SE (1) SE325579B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542784A (en) * 1968-04-05 1970-11-24 Norwich Pharma Co 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines
US3705898A (en) * 1970-01-26 1972-12-12 Morton Norwich Products Inc Certain 4 - amino - 2-(5-nitro-2-thienyl) quinazolines and the intermediate 4 - chloro-(5 - nitro-2-thienyl)quinazolines therefor
CH612432A5 (en) * 1975-05-12 1979-07-31 Sandoz Ag
JP2657760B2 (en) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4-aminoquinazoline derivatives and pharmaceuticals containing them
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
CN1832941A (en) * 2003-08-08 2006-09-13 尤利塞斯药品公司 Halogenated quinazolinyl nitrofurans as antibacterial agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265777A (en) * 1960-06-09

Also Published As

Publication number Publication date
SE325579B (en) 1970-07-06
BR6575667D0 (en) 1973-09-06
NL6513634A (en) 1966-06-15
FR1460221A (en) 1966-06-17
ES318292A1 (en) 1967-03-01
CH448110A (en) 1967-12-15
BE672504A (en) 1966-03-16
AT255424B (en) 1967-07-10
DK117902B (en) 1970-06-15
US3324122A (en) 1967-06-06
GB1101179A (en) 1968-01-31
DE1620076A1 (en) 1970-02-12
FR4910M (en) 1967-03-13
IL24359A (en) 1969-01-29

Similar Documents

Publication Publication Date Title
SU1015827A3 (en) Process for preparing derivatives of quinoline carboxylic acid or their hydrates
EP0004279B1 (en) Process for the preparation of 4-pyridone-3-carboxylic acids, 1-cyclopropyl-4-pyridone-3-carboxylic acid derivatives and medicines containing them
US4188486A (en) 2-Substituted benzimidazole compounds
NO118066B (en)
NO138422B (en) PROCEDURE AND SYSTEM FOR CALCINATION OF POWDERED MATERIAL CONTAINING LIME
US4218457A (en) 2-Substituted 5-hydroxy-1H-imidazole-4-carboxamide derivatives and use
DK160421B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4-OXO-1,4-DIHYDRONICOTIC ACID DERIVATIVES OR SALTS THEREOF
NO122124B (en)
EP0003144B1 (en) 4-pyridone-3-carboxylic acid derivatives, pharmaceutical compositions containing them, processes for their preparation, their application
US4436913A (en) 1H- and 2H- indazole derivatives
DE2707268A1 (en) Indole-3-carboxaldehyde oxime derivs. - with hypouricaemic, analgesic, antiinflammatory, hypoglycaemic, cardiovascular and diuretic activity
US4192880A (en) 2-Substituted benzimidazole compounds
SU772482A3 (en) Method of preparing 4-diphenylmethylene-1-hydroxybenzyl-piperidines or their salts
US4448777A (en) 1-Phenylindazole-3-one compounds, process and intermediates for their preparation, and pharmaceutical compositions containing same
JPH06298611A (en) Antibacterial agent
US3674787A (en) 2-(alpha-morpholinobenzyl)-anilides
US4594419A (en) Substituted 5-phenylthio-6-amino-pyrimidinones, a process for their preparation and their use, and formulations containing these compounds
NO141757B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1- (2- (BETA-Naphthyloxy) Ethyl) -3-Methyl-PYRAZOLONE- (5) AND ITS SALTS
Burch Nitrofuryl Heterocycles. IV1. 4-Amino-2-(5-nitro-2-furyl) quinazoline Derivatives
CN115703737B (en) Hydroxypyridones compound and application thereof as antibiotic sensitizer for overcoming bacterial biomembrane resistance
US4235899A (en) Substituted O-(2-hydroxypropyl)-aldoximes
US4255585A (en) Benzoheterocyclic derivatives of phenoxyacetic acid
US3904586A (en) Novel benzyloxysulfamides
HU184772B (en) Process for preparing quinoxaline-1,4-dioxide derivatives
WO1996002540A1 (en) Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents